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ABSTRACT 
 
B cells encounter antigen over a wide affinity range, from KA=105 M-1 to KA=1010 M-1.  
The strength of B cell signaling in response to antigen increases with affinity, a process 
known as “affinity discrimination”.  In this work, we use a computational simulation of B 
cell surface dynamics and signaling to show that affinity discrimination can arise from 
the formation of BCR oligomers.  It is known that BCRs form oligomers upon 
encountering antigen, and that the size and rate of formation of these oligomers increase 
with affinity.  In our simulation, we have introduced a requirement that only BCR-
antigen complexes that are part of an oligomer can engage cytoplasmic signaling 
molecules such as Src-family kinases.  Our simulation shows that as affinity increases, 
not only does the number of collected antigen increases, but so does signaling activity.  
Our results are also consistent with the existence of an experimentally-observed threshold 
affinity of activation at KA=105-106 M-1 (no signaling activity below this affinity value) 
and affinity discrimination ceiling of KA=1010 M-1 (no affinity discrimination above this 
affinity value).  Comparison with experiments shows that the time scale of dimer 
formation predicted by our model (less than 10 s) is well within the time scale of 
experimentally observed association of BCR with Src-family kinases (10-20 s).      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
B cells, the cells responsible for antibody production, are activated by recognizing 
antigen (Ag) through the B cell antigen receptor (BCR) located on their surface.  The 
strength of BCR signaling in response to stimulation by antigen is known to increase 
monotonically with antigen affinity, a phenomenon known as “affinity discrimination” 
[1-9].  B cell affinity discrimination is critical to the process of affinity maturation that 
results in the production of high affinity antibodies [9], and is thus important in 
applications such as vaccine design [9].  The precise mechanisms by which B cells 
receptors sense antigen affinity are still not fully known [10].  While the first studies of B 
cell affinity discrimination focused on multivalent antigen encountered in soluble form, 
recent research shows that antigens presented on the surface of antigen presenting cells 
(APCs), typically dendritic cells or macrophages, are potent stimulators of B cells [4,10-
21].  
Further studies have shown that during the initial stages of contact between B 
cells and APCs, micro-clusters of 10-100 BCR-antigen complexes form on protrusions of 
the B cell surface [8,9,13,22,23].  These micro-clusters are signaling-active 
[8,9,13,22,23], as they trigger affinity-dependent spreading of the B cell surface over the 
antigen presenting cell surface, increasing the cell-cell contact area [8].  This spreading 
response leads to the formation of micro-clusters at the leading edges [8,22], culminating 
in the formation of the immunological synapse [7,8,10,12].  It has also been shown that 
early signaling events (~100 seconds) such as Ca2+ flux, as well as antigen accumulation 
in the immunological synapse, all increase with antigen affinity [8,9].  Thus, affinity 
discrimination has been observed at the earliest stages of contact between B cell receptors 
and antigen [8,9].   
However, little is known about how B cells discriminate between membrane 
antigens of varying affinity at the level of BCR-antigen micro-clusters.  In previous work, 
we showed that kinetic proofreading [24,25] was needed to generate the affinity 
discrimination pattern observed in B cell affinity discrimination experiments [26].  
Kinetic proofreading was simulated in an ad hoc manner, by introducing a threshold time 
for which antigen had to stay bound to a BCR before that BCR could engage cytoplasmic 
signaling molecules.  The kinetic proofreading requirement, in the form of the threshold 
time, needed to be long enough to predominate over the competing effect of reduced 
serial engagement with increasing affinity, which was detrimental to affinity 
discrimination.  In the absence of a kinetic proofreading requirement, our previous 
modeling studies demonstrated that the strength of B cell signaling actually decreased as 
affinity increased, which is the opposite of B cell affinity discrimination.  However, the 
physical mechanism that could give rise to kinetic proofreading still needs to be explored 
in terms of molecular level interactions. 
 It is known that BCRs form oligomers in the presence of antigen [9,27], leading 
to the formation of the larger BCR-antigen microclusters reported in the literature.  
However, the molecular mechanism of BCR oligomer formation is not known.  While 
cross-linking by soluble multivalent antigens has traditionally been used to explain BCR 
oligomer formation, such a mechanism cannot account for the formation of BCR 
oligomers in the presence of monovalent, membrane-bound antigen [7-9,22,28,29].  
According to the “conformation-induced oligomerization model” of Pierce and 
colleagues, the force exerted by membrane-bound antigen binding to BCR within the 
restricted 2-D geometry of a cell-cell interaction opens up the Cµ4 domain at the base of 
the BCR ectodomain into a conformation that is conducive to oligomer formation [27-
29].  When a BCR with an “open” Cµ4 domain encounters another BCR with its Cµ4 
domain also “open”, the two may form a dimer [27-29]. 
Here, we explored whether Pierce’s confirmation-induced model of oligomer 
formation can account for B cell affinity discrimination.  We removed the threshold time 
requirement, and instead introduced a requirement that only BCRs that have bound 
antigen can form oligomers, and only BCRs that are part of an oligomer can engage 
cytoplasmic signaling molecules.  Such a requirement favors high affinity interactions, 
since as affinity increases, the antigen off-rate generally decreases.  Higher affinity BCR-
antigen pairs thus have a longer lifetime, which increases the odds of their encountering 
another BCR-antigen pair and forming an oligomer; the stability of formed oligomers is 
also enhanced with increasing affinity. Since only BCRs in oligomers can engage 
signaling molecules, there should be more signaling activity as affinity increases. Hence 
oligomer formation emerges as a kinetic proofreading mechanism that enables B cells to 
discriminate between antigens of different affinities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHOD 
 
Our method is a three-dimensional, agent-based Monte Carlo simulation of BCR-
antigen binding at the surface and membrane-proximal BCR signaling in the cytoplasm.  
The current method is based on our previous work [26,30].  We modeled the B-cell 
signaling pathway as far the Src family kinase Syk. The molecular species included in 
our model are BCR (and its Ig-α and Ig-β signaling subunits), antigen (Ag), and the 
kinases Lyn and Syk. Individual molecules are explicitly simulated as discrete agents 
reacting with each other and diffusing subject to probabilistic parameters that can be 
mapped to kinetic rate constants.   
 
Setup 
Because we are interested in the early stages of antigen recognition, we model a 
single protrusion on a B cell surface, its cytoplasmic interior, and its vertical projection 
onto a planar bilayer containing antigen.  The bilayer and B cell protrusion tip are 
modeled as lattices of 150×150 nodes, while the interior of the B cell protrusion is 
modeled to a depth of 40 nodes.  We only allow one molecule per node, thus we set the 
spacing between nodes to 10 nm, roughly the exclusion radius of a membrane protein 
molecule. The domain size thus corresponds to a physical area of 1.5 µm × 1.5 µm. BCR 
is located on the B cell protrusion surface, antigen on the bilayer surface, Lyn is anchored 
below the B cell protrusion surface, and Syk is distributed in the B cell protrusion’s 
cytoplasm.  At the start of a simulation run, all of these species are distributed uniformly 
at random over their respective domains.  At each time step, individual molecules in the 
population are randomly sampled to undergo either diffusion or reaction, determined by 
means of an unbiased coin toss. 
 
Reaction 
 Antigen, Lyn and Syk are monovalent, while BCR molecules possess four 
binding sites: Two extracellular Fab domains for antigen binding, and one Ig-α and one 
Ig-β cytoplasmic domain, both of which serve as binding sites for Lyn and Syk.  If an 
antigen molecule is selected for reaction, the lattice node on the B cell surface directly 
opposite the antigen’s location is checked for a Fab domain, and if that is the case, a 
BCR-Ag complex may form with probability pon(BA).  If the target BCR molecule happens 
to also have an antigen bound on the other Fab domain, a BCR-Ag2 complex will form.  
If a BCR molecule is selected to undergo reaction, an unbiased coin toss is performed to 
chose between the extracellular or cytoplasmic domains, and an additional unbiased coin 
toss is performed to chose one of the Fab domains (left or right), or either the Ig-α or Ig-β 
domain, depending on the result of the preceding coin toss.  If a free Fab domain is 
selected, the node on the bilayer surface directly opposite is checked for antigen, which 
may bind with probability pon(BA).     If the selected Fab domain already has an antigen 
bound to it, the BCR-Ag bond may dissociate with probability poff(BA).   
 If a BCR-Ag or BCR-Ag2 complex is next to another BCR-Ag or BCR-Ag2 
complex, they may form a dimer with probability pon(olig). This can happen either via 
reaction (a BCR binding an antigen right next to a BCR-Ag or BCR-Ag2 complex), or 
diffusion (a BCR-Ag or BCR-Ag2 complex moving next to another BCR-Ag or BCR-Ag2 
complex).  Another BCR-Ag or BCR-Ag2 complex may subsequently form or diffuse 
next to the dimer, and join the dimer with probability pon(olig), forming a trimer.  The 
theoretical upper bound on the size of an oligomer is only limited by the number of BCR 
and antigen molecules in the simulation, whichever is smaller.  All BCRs within an 
oligomer lose the ability to diffuse, however they gain the ability to bind Lyn on either 
their Ig-α or Ig-β domains.  Lyn may bind with probability pon(Lyn), either via sampling of 
the Ig-α or Ig-β domains for reaction, or sampling of a Lyn molecule for reaction (similar 
to antigen binding on the Fab domains).  Upon binding, Lyn may phosphorylate the Ig-α 
or Ig-β domain it is bound to with probability pphos(Lyn).  A bound Lyn may dissociate with 
probability poff(Lyn) if the Ig-α or Ig-β domain to which it is bound is sampled. Before the 
dissociation trial with probability poff(Lyn) is carried out, a phosphorylation trial with 
probability pphos(Lyn) is performed.   
If a BCR that is part of an oligomer loses all of its bound antigens through 
dissociation, it ceases being part of the oligomer, regaining its ability to diffuse but losing 
the ability to bind Lyn.  Depending on whether its neighboring BCR/Ag or BCR/Ag2 
complexes neighbor other BCR/Ag or BCR/Ag2 complexes, they may also revert to the 
un-oligomerized state.  For example, if one of the BCRs in a dimer is no longer bound to 
antigen, the other BCR formerly in the dimer also regains the ability to diffuse and loses 
the ability to bind Lyn.  Similarly, if the BCR in the middle of a trimer is no longer bound 
to antigen, all three BCRs revert to the un-oligomerized state. However, if the BCR at the 
edge of a trimer is no longer bound to antigen, the other two BCRs remain in a dimer 
configuration.  
Syk may bind to Ig-α or Ig-β domains that have been phosphorylated by Lyn 
(BCRs with at least one Ig-α or Ig-β domain phosphorylated by Lyn are designated 
pBCR), initially with probability pon(Syk)low.  Upon binding, Syk may phosphorylate the 
Ig-α or Ig-β domain it is bound to with probability pphos(Syk)low.  If the phosphorylation 
trial by Syk is successful, the pBCR molecule with at least one Ig-α or Ig-β domain 
phosphorylated by Syk is designated as a ppBCR molecule. Also, if the phosphorylation 
trial is successful, the Syk molecule may itself become phosphorylated (phosphorylated 
Syk molecules are designated pSyk), either by a Lyn molecule or another pSyk molecule 
located on a neighboring node, with probability psyk(phos). If the phosphorylation trial is 
unsuccessful, and the pBCR molecule does not transition to the ppBCR state, the Syk 
molecule also remains in the inactive state (designated iSyk) and will not become 
phosphorylated by a Lyn or pSyk (at the start of the simulation, all Syk molecules are in 
the iSyk state).  A phosphorylation trial of Ig-α or Ig-β by Syk occurs every time the Ig-α 
or Ig-β to which the Syk is attached is sampled for dissociation. 
The dissociation kinetics of Syk attached to an Ig-α or Ig-β domain depend on the 
phosphorylation status of the Syk and the Ig-α or Ig-β domain it is bound to.  If the 
phosphorylation trial by Syk is unsuccessful, and the Syk molecule remains in the iSyk 
stage and BCR molecule in the pBCR stage, the Syk molecule may dissociate with 
probability poff(Syk)high.  If the phosphorylation trial is successful, the Syk molecule will 
dissociate with probability poff(Syk)high from the ppBCR if the Syk molecule is successfully 
phosphorylated by a nearby Lyn or pSyk (becoming a pSyk molecule in the process).  
However, if the phosphorylation trial is successful but the Syk molecule is not 
phosphorylated by a nearby Lyn or pSyk molecule, the probability of the iSyk molecule 
dissociating is governed by poff(Syk)low, and it remains in the iSyk state. 
Later in the simulation it is possible for an iSyk molecule to encounter a ppBCR 
that has reached that state from previous interactions.  In that case, it may bind to the Ig-α 
or Ig-β domains with probability pon(Syk)high.  The dissociation kinetics in such an instance 
are as described above:  If the Syk molecule is phosphorylated by a nearby Lyn or pSyk, 
the probability used in subsequent dissociation trials is poff(Syk)high and the attached Syk 
molecule transitions to the pSyk state.  However if the Syk molecules is not 
phosphorylated, it remains in the iSyk state and the probability used in subsequent 
dissociation trials is poff(Syk)low. 
A pSyk molecule encountering a pBCR or ppBCR may bind the Ig-α or Ig-β 
domains with probability pon(Syk)low and dissociate with probability poff(Syk)high.  In the case 
of a pSyk molecule binding to a pBCR molecule, the probability of the pBCR becoming 
phosphorylated by the pSyk molecule and transitioning to the ppBCR state is governed 
by pphos(Syk)high.  Lastly, a pSyk molecule that is diffusing in the cytoplasm may also 
phosphorylate an iSyk molecule it encounters with probability pphos(SykSyk). The kinetic 
rules for Syk are summarized in Table 1.  These simulation rules for Syk are significantly 
more complex than those used in our previous work, and are based on a survey of the 
literature on the subject [31-34]. 
 
Diffusion 
If a molecule has been selected to undergo diffusion, a random number trial with 
probability pdiff(i) is used to determine whether the diffusion move will occur.  The 
diffusion probability pdiff is directly analogous to the diffusion coefficient D.  The 
probability of diffusion of free molecules is denoted by pdiff(F), and that of BCR-antigen 
complexes and BCR signalosomes by pdiff(C).  If the trial with probability pdiff(i) is 
successful, a neighboring node is selected at random (4 possibilities for BCR, antigen, 
and Lyn, 6 possibilities for Syk) and the target node is checked for occupancy.  The move 
will occur only if the target node is vacant, as no two molecules are allowed to occupy 
the same node.  BCR molecules, BCR-antigen complexes, and BCR signalosomes are 
generally assumed to be much larger than antigen, Lyn and Syk molecules and occupy 
several nodes; thus in these instances there will be several target nodes that need to be 
vacant for the move to occur.  BCR-antigen complexes and BCR signalosomes are 
generally assumed to diffuse slower than free molecules [22], hence pdiff(C) is an order of 
magnitude lower than pdiff(F).  Since free receptor and ligand molecules are the fastest 
diffusing species, we set pdiff(F)=1, and pdiff(C)=0.1.   
 
Sampling and time step size 
In our algorithm, the entire molecular population is randomly sampled M times 
for diffusion or reaction during every time step.  Whether a diffusion or reaction trial will 
occur is determined by means of an unbiased coin toss.  The number of trials M is set 
equal to the total number of molecules (free plus bound) present in the system at the 
beginning of each time step, and the simulation is run for a number of time steps T.    
A distinguishing feature of our method is a mapping between the probabilistic 
parameters of the Monte Carlo simulation and their physical counterparts.  We do this by 
setting pdiff of the fastest diffusing species, in this case free molecules (pdiff(F)), equal to 1 
and matching that quantity to the species’ measured diffusion coefficient D. The 
diffusion coefficient of free molecules on a cell membrane has been experimentally 
measured to be of the order of 0.1 µm2/s [35]. In one time step, a molecule with pdiff=1 
will on average (since each molecule is on average sampled once per time step) have 
covered a distance of one nodal spacing, or 10 nm, giving a mean square displacement 
<r2> of 10-4 µm2.  Using <r2>=Dt, this results in a time step size of 10-3 seconds.  Once 
the time step size is known, it is possible to map pon, poff, and their ratio PA to their 
respective physical counterparts, kon, koff, and KA.  A detailed description of the mapping 
process can be found in our previous work [26]. Such a mapping makes it possible to 
compare our model’s results to those of physical experiments to within an order of 
magnitude, without a priori setting of the simulation timescale. 
 
Model parameters 
The parameters used in our model are listed in Table 2.  Parameter values used in 
our simulations are given on the left side of Table 2.  Their physical equivalent is listed 
on the right side of Table 2.  Where possible, the value of the physical quantity is taken 
from the literature, and mapped back into a value that can be used in our simulation.  This 
is the case for BCR-antigen kinetic parameters (PA(BA), pon(BA), poff(BA)), the number of 
BCR and antigen molecules (B0, A0), and the diffusion probability of free molecules 
(pdiff(F)).  We vary BCR-antigen affinity by orders of magnitude across the physiological 
range for B cells (KA=105-1010 M-1).  BCR-antigen affinity is initially varied, as in many 
B cell activation experiments [7,8], by keeping kon constant and varying koff.  For 
example, in Carrasco et al. [7], affinity for the HEL series of antigen is varied by varying 
koff across five orders of magnitude, while kon is fixed at 2*106 M-1s-1 [7,8].  This value 
maps to a probability of 0.1 according to our mapping scheme, while the reported koff 
values ranging from 101 to 10-4 s-1 map to poff values of 10-2-10-7 for a time step size of 
10-3 s.  In the Supporting Information, we show the effect of varying kon.  Variation in kon 
(and/or koff) commonly occurs when higher affinity BCRs are generated through somatic 
hypermutation during the affinity maturation process [36]. The literature value of 105 
receptors/cell [37] maps to 400 molecules for the 1.5 µm × 1.5 µm domain used in our 
simulations, while the antigen concentration of 10-100 molecules/µm2 used in 
experiments [7] maps to 20-200 antigens.  In the results shown here we used 200 antigen 
molecules, and results with 20 and 2000 antigen molecules are included in the Supporting 
Information.   
We also vary the values of parameters for which we were not able to find 
measured values in the literature, such as the number of Lyn and Syk molecules (L0, S0),  
the probability of oligomer formation, pon(olig), the on and off-probabilities of cytoplasmic 
reactions such as pon(Lyn), poff(Lyn), pon(Syk)low, pon(Syk)high, poff(Syk)low, poff(Syk)high, and the 
phosphorylation reaction probabilities pphos(Lyn), pphos(Syk)low, pphos(Syk)high, pSyk(phos), and 
pphos(SykSyk). For the purposes of obtaining ballpark values for these parameters, we have 
adapted the values used in modeling studies of FcεRI-mediated signaling, which bears 
many similarities to BCR-mediated signaling [38,39].  Starting from the ballpark values, 
we performed parametric studies to gauge the effect of these parameters on affinity 
discrimination.  These parametric studies are included as Supporting Information.  Here, 
we show the results obtained for those parameter values that resulted in the best affinity 
discrimination, while still being physically reasonable.  These are the values shown on 
the left of Table 1, with their mapped physical values shown on the right (though these 
are not literature values). 
RESULTS 
 
Histogram plots show affinity discrimination from bound antigen to phosphorylated Syk 
 We investigate affinity discrimination by tabulating the quantity of several 
relevant molecular species at the end of a simulation run of 100 physical seconds (i.e. 105 
Monte Carlo simulation time steps).  The quantities of interest are 1) the number antigen 
bound to BCR (bdAg), 2) the number of BCRs that are part of an oligomer (dBCR), 3) 
the number of BCRs with at least one ITAM singly phosphorylated by Lyn (pBCR), 4) 
the number of BCRs with at least one ITAM doubly phosphorylated by Syk (ppBCR), 
and 5) the number of phosphorylated Syk (pSyk).  Because our simulation is stochastic in 
nature, these quantities vary from one run to the next. We therefore perform one thousand 
independent trials for each affinity value and plot the results in histograms.  BCR-antigen 
affinity is varied by orders of magnitude across the physiological range, from KA=105 M-1 
to KA=1010 M-1, as is done in some B cell affinity discrimination experiments [7,8]. 
Histogram plots of the number of bound antigen molecules are shown in Figure 1.  In line 
with experimental results [8], the number of bound antigen molecules increases with 
BCR-antigen affinity.  The histogram plots for the four lowest affinity values (KA=105 M-
1 to KA=108 M-1) are well separated, and it also is possible to distinguish between KA=108 
M-1 and KA=109 M-1. The histograms for KA=109 M-1 and KA=1010 M-1 almost completely 
overlap, indicative of the ceiling in affinity discrimination around KA=1010 M-1 observed 
in the experimental literature [2,8]. 
 Histogram plots of the number of dBCR are shown in Figure 2. As with bound 
antigen, the four lowest affinity values are clearly separated, it is possible to distinguish 
between KA=108 M-1 and KA=109 M-1, while the histograms for KA=109 M-1 and KA=1010 
M-1 almost completely overlap. Importantly, the number of dBCR is close to zero for all 
trials at the lowest affinity value, KA=105 M-1. This is in agreement with the existence of a 
threshold affinity for B cell activation, such as KA=106 M-1 observed in some B cell 
activation experiments [2,7,8], below which no B cell activation is observed.  Since our 
simulations show that there is a nonzero number of bdAg at KA=105 M-1, this result 
suggests that lack of dimer formation below affinity KA=106 M-1 could be one reason for 
the absence of B cell activation below this affinity value.    
 The number of singly phosphorylated BCR, pBCR, is shown in Figure 3. The 
histograms are less clearly separated than in Figures 1 and 2, though it is still possible to 
distinguish between KA=107 M-1 and KA=108 M-1, and to a lesser extent between KA=108 
M-1 and KA=109 M-1.  Nevertheless, the results in Figure 3 closely resemble those of 
Figure 2.  As in Figure 2, the number of pBCR for KA=105 M-1 is usually zero (only for a 
relatively few trials is this number nonzero).  
The number of doubly phosphorylated BCR, ppBCR is shown in Figure 4. The 
pattern resembles that of Figure 3, the main difference being that the number of ppBCR 
for KA=106 M-1 is much smaller, and for KA=105 M-1 is zero for all trials. Thus, affinity 
discrimination seen in Figures 1 and 2 is maintained at the level of pBCR and ppBCR, 
albeit with some loss.  
The number of phosphorylated Syk is shown in Figure 5. It is still possible to 
distinguish between KA=107 M-1, KA=108 M-1, and KA=109 M-1, thus affinity 
discrimination is still evident at the level of pSyk.  The histograms in Figure 5 have 
noticeably higher standard deviations than those of Figs 1-4.  Of note is that our results 
reproduce the threshold affinity of activation at KA=106 M-1 and affinity discrimination 
ceiling at KA=1010 M-1 all the way down to the level of pSyk.   
 
Analysis of histogram overlaps: quantitative metric for affinity discrimination 
We quantify affinity discrimination in the histograms of Figure 1-5 using the 
metric Δ=(overlap area)/(m1–m2), where the area of overlap between the histograms for 
two adjacent affinity values is divided by m1 and m2, the histograms’ mean values for 
those two affinities. Lower Δ values correspond to better affinity discrimination, with the 
best discrimination occurring at Δ=0 (no overlap between histograms). When Δ=0, it is 
necessary to compare the mean values of the histograms (Figure 7).  In Figure 6, we show 
Δ for the quantities in Figures 1-5.  For 106 M-1/105 M-1 and 107 M-1/106 M-1 there is full 
separation, with increases in Δ thereafter.  Bound antigen has the lowest Δ, indicating a 
loss in affinity discrimination downstream, although this loss is proportionately small for 
108 M-1/107 M-1 and to a lesser extent for 109 M-1/108 M-1. For 1010 M-1/109 M-1, we note 
that the histograms in Figures 1-5 almost completely overlap, while in Figure 6 the value 
of Δ is 200 or greater. We thus take Δ=200 or greater to indicate absence of affinity 
discrimination. 
 
Mean value plots show a sigmoid affinity discrimination profile with increasing affinity 
In Figure 7, we plot the trial-averaged (mean) values of the quantities represented 
in the histograms of Figures 1-5. Trial-averaged quantities are important as they can be 
thought of as analogous to the signaling response integrated from multiple protrusions on 
a single cell.  All five quantities plotted show a monotonic, sigmoid increase with 
affinity, starting with a small increase from KA=105 M-1 to KA=106 M-1, a steeper 
increases between KA=106 M-1 and KA=107 M-1, leveling off as the ceiling of KA=1010 M-1 
is approached. The strength of BCR signaling is known from experiments to increase 
monotonically with affinity, and our simulation results reproduce this.  As shown in the 
Supporting Information, the affinity discrimination pattern, activation threshold and 
affinity discrimination ceiling in our above results are generally robust with regards to 
variations in individual parameter values. 
 
Average time of initial oligomer formation shows a non-linear decrease with increasing 
affinity 
In Figure 8, we show the trial-averaged time of formation of the first oligomer 
(almost always a dimer).  In every simulation trial, the time at which the first oligomer 
forms is recorded, and the results for each affinity value are averaged over 1000 trials and 
plotted in Figure 8.  The average time of initial oligomer formation decreases by about 
half from KA=105 M-1 to KA=106 M-1, with smaller decreases as affinity increases 
thereafter.  The relatively high time of initial oligomer formation for KA=105 M-1 is due to 
the high value of koff at this affinity value, which results in a low rate of oligomer 
formation.  The times shown in Figure 8 are well within the experimentally observed ~10 
second timescale of BCR association with Lyn [22,23].  The standard deviation of the 
time of initial oligomer formation is roughly 6 s for KA=105 M-1, and roughly 2 s for all 
affinity values above that.  
 
 
Time series plots for signaling activation 
 Plots of the trial-averaged number of bdAg, dBCR, pBCR, ppBCR, and aSyk as 
functions of time are shown in Figure 9.  The number of bdAg, dBCR and pBCR 
approaches equilibrium after T=105 time steps, particularly for the lower affinity values, 
but the number of ppBCR and pSyk is still far from equilibrium. This is to be expected, 
as these quantities are further downstream in the signaling pathway.  The plots in Figure 
9 are also in agreement with the experimental finding of faster growth in signaling for 
higher affinity values [9]. For the lowest affinity value, KA=105 M-1, the number of 
dBCR, pBCR, ppBCR and pSyk is close to zero for all times.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 In this work, we show that the process of oligomer formation gives rise to the 
kinetic proofreading that we showed in previous work was necessary for B cells to 
discriminate antigen affinity.  Our work here does not contain an explicit, ad hoc kinetic 
proofreading requirement, rather, kinetic proofreading emerges naturally from our 
simulation.  Our results clearly show that just as the number of antigen bound to BCR 
increases with affinity, so does the number of phosphorylated Syk molecules.  Though 
there is some loss in definition, the affinity discrimination pattern observed at the level of 
BCR-antigen complexes is observable at the level of phosphorylated Syk molecules.  
Because of their longer lifetime, high affinity BCR-antigen pairs are more likely 
to encounter one another and form an oligomer.  This is reflected in our finding that the 
average time of dimer formation decreases with affinity.  More oligomer formation 
directly leads to more phosphorylation of BCR ITAMs by Lyn, which in turn leads to 
more Syk activity. If BCRs could associate with Lyn immediately upon encountering 
antigen, signaling strength would have decreased with affinity, as shown in our previous 
work [26].  The requirement that BCR not only needs to bind antigen, but also encounter 
another BCR-antigen pair and form a dimer, acts as a type of kinetic proofreading and 
results in affinity discrimination as observed in experiments. This type of oligomer 
formation-mediated mechanism of affinity discrimination would ensure that significant 
affinity discrimination is achieved even between closely related antibodies, such as those 
generated during the process of affinity maturation.  
Our simulation results are also consistent with the existence of an experimentally 
observed threshold affinity of activation and affinity discrimination ceiling. Our 
simulations predict a B cell activation threshold at KA=106 M-1, as shown by the fact that 
the number of dBCR and other downstream quantities is zero below KA=106 M-1, even 
though the number of bound antigen at KA=105 M-1 is nonzero.  This indicates that the 
threshold of B cell activation for downstream quantities is at least an order of magnitude 
higher than that for bound antigen.  The precise value of the threshold affinity of 
activation and affinity discrimination ceiling may vary from one experimental setup to 
another (depending on the cell line used, antigen family, etc…), however the existence of 
the affinity threshold and affinity discrimination ceiling is established by experiments.  
Similarly, in our simulation the precise value of the threshold and ceiling may vary 
depending on the parameter values used, however, they are always present, as shown in 
the Supporting Information.  The B cell activation threshold could also be modulated by 
lipid-mediated interactions, such as those between BCRs and raft-forming sphingolipids, 
which could perturb the natural lipid environment of resting B cells.  For example, the 
formation of BCR oligomers is difficult for BCRs with low kon, but lipid mediated 
mechanisms can lower the affinity threshold in such cases. A detailed model of BCR-
lipid raft formation, which includes both BCR-BCR interactions (that can result in BCR 
oligomer formation) and BCR-lipid interactions, is currently under development.    
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Table 1.  Kinetic rules for Syk used in our simulation.  
 pBCR ppBCR 
iSyk Binds with pon(Syk)low 
Phosphorylates Ig-α/β with pphos(Syk)low 
Unbinds with poff(Syk)high 
Binds with pon(Syk)high 
Unbinds with poff(Syk)low 
pSyk Binds with pon(Syk)low 
Phosphorylates Ig-α/β with pphos(Syk)high 
Unbinds with poff(Syk)high 
Binds with pon(Syk)high 
Unbinds with poff(Syk)high 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Parameters of our model, and their physical equivalents.   
Simulation 
parameter 
Value Physical equivalent Value 
PA(BA)  101-106 ‡ KA BCR-antigen 105-1010 M-1 [7,8] 
pon(BA)  0.1‡ kon BCR-antigen 106 M-1s-1 [7,8] 
poff(BA)  10-2-10-7 ‡ koff BCR-antigen 101-10-4 s-1 [7,8] 
B0 400 molecules BCR molecules/cell ~105 [37]  
A0 200 molecules ‡ Antigen conc. 100 molec./µm2 [7] 
L0 100 molecules †‡ Lyn molecules/cell 2×104 
S0 400 molecules †‡ Syk molecules/cell 4×105 
pdiff(F) 1  Dfree molecules 0.1 µm2/s [35] 
pdiff(C) 0.1 Dcomplexes ~0.01 µm2/s [22] 
pon(olig) 0.1‡ kon(BCR-BCR) 100 molec-1×s-1 
PA(Lyn) 102 †‡ KA Ig-α/β-Lyn 106 M-1  
pon(Lyn) 1.0 †‡ kon Ig-α/β-Lyn ~107 M-1 s-1  
poff(Lyn) 0.01 †‡ koff Ig-α/β-Lyn ~10 s-1 
pon(Syk)high 1.0 †‡ kon Ig-α/β-Syk  ~107 M-1 s-1 
pon(Syk)low 0.1 †‡ kon Ig-α/β-Syk  ~106 M-1 s-1 
poff(Syk)high 1.0 †‡ koff Ig-α/β-Syk ~1000 s-1 
poff(Syk)low 0.001 †‡ koff Ig-α/β-Syk ~1 s-1 
pphos(Lyn) 0.1 †‡ kphos(Lyn) ~100 s-1 
pphos(Syk)high 1.0 †‡ kphos(Syk)high ~1000 s-1 
pphos(Syk)low 0.5 †‡ kphos(Syk)low ~500 s-1 
pSyk(phos) 1.0 †‡ kSyk(phos) ~1000 s-1 
pphos(SykSyk) 0.01 †‡ kphos(SykSyk) ~10 s-1 
† Represents a ballpark value calculated from [38,39] 
‡ Parametric study performed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
 
Figure 1.  Histogram plots of the number of bound antigen molecules.  BCR-antigen 
affinity is varied by orders of magnitude across the physiological range in B cells, KA=105 
M-1 to KA=1010 M-1.  Because of the probabilistic nature of our simulation, one thousand 
trials were performed for each affinity value.  The parameter values used are those listed 
in the left column of Table 2, simulation time is 105 time steps (corresponding to T=100 
physical seconds).  The number of bound antigen generally increases with affinity, as 
expected. 
 
Figure 2.  Histogram plots of the number of BCRs that are part of an oligomer.  All 
BCRs in the simulation are checked whether they are part of an oligomer, and if they are, 
they are included in the tally.  One thousand trials, 105 time steps, with the parameters 
listed in the left of Table 2.  As with the number of bound antigen, the number of 
oligomerized BCR increases with affinity. 
 
Figure 3.  Histogram plots of the number of BCR molecules with at least one ITAM 
phosphorylated by Lyn.  Included in the histograms is any BCR with at least one ITAM 
phosphorylated by Lyn.  One thousand trials, 105 time steps, with the parameters listed in 
the left of Table 2.  As with upstream quantities (bound antigen, oligomerized BCR), the 
number of Lyn-phosphorylated BCRs increases with affinity. 
 
Figure 4.  Histogram plots of the number of BCR molecules with at least one ITAM 
phosphorylated by Syk.  Included in the histograms is any BCR with at least one ITAM 
phosphorylated by Syk.  One thousand trials, 105 time steps, with the parameters listed in 
the left of Table 2.  As with upstream quantities, the number of Syk-phosphorylated BCR 
increases with affinity. 
 
Figure 5.  Histogram plots of the number of phosphorylated Syk molecules.  Includes 
any Syk molecule that is in the phosphorylated state, whether attached to an Ig-α/β or 
freely diffusing in the cytoplasm. One thousand trials, 105 time steps, with the parameters 
listed in the left of Table 2.  As with upstream quantities, the number of twice-
phosphorylated Syk increases with affinity. 
 
Figure 6.  Quantitative comparison of affinity discrimination between adjacent 
affinity values. Plots of the quantity Δ=(overlap area)/(m1 – m2), where Δ, the area of 
overlap between the histograms for two adjacent affinity values (e.g. KA=107 M-1 and 
KA=108 M-1) is divided by m1 and m2, the histograms’ mean values. A lower value of Δ 
corresponds to better affinity discrimination, while for the case of Δ=0 one needs to 
compare the difference between mean values (Fig. 7).  Affinity discrimination decreases 
with affinity, and also downstream of BCR-antigen binding. 
 
 Figure 7.  Plots of the mean values of the histogram plots in Figs. 1-5.  All five 
quantities plotted in the histograms of Figs. 1-5 show a monotonic, sigmoid increase with 
affinity. 
 
Figure 8.  Plot of the trial-averaged time of initial dimer formation for each affinity 
value simulated.  For each trial, the time at which the first dimer forms is recorded, and 
the average over one thousand trials is plotted here.  This quantity decreases with affinity, 
and the average time of initial dimer formation for the lowest affinity value, KA=105 M-1 
is about twice that of higher affinity values. 
 
Figure 9.  Plot of the mean values of the histograms in Figs. 1-5 as functions of time.  
We record the mean value of the quantities plotted in Figs. 1-5 over 105 time steps, and 
plot the results in Fig. 9.  All quantities increase monotonically with affinity, with the 
number of bound antigen, oligomerized BCR, and Lyn-phosphorylated BCR approaching 
equilibrium. 
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